Omada Health (OMDA) director Jonathan Root receives 820 RSUs in lieu of fees

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

ROOT JONATHAN D reported acquisition or exercise transactions in this Form 4 filing.

Omada Health, Inc. director Jonathan D. Root received a grant of 820 restricted stock units as part of the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each unit represents one share of common stock, granted at no cash cost. Following this award, Root holds 191,877 shares of common stock directly, including the RSUs, with settlement to occur on a date selected under the program or as otherwise provided by that program.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider ROOT JONATHAN D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	820	$0.00	--

Holdings After Transaction: Common Stock — 191,877 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

RSUs granted: 820 units Price per RSU: $0.0000 per share Shares held after grant: 191,877 shares +2 more

5 metrics

RSUs granted 820 units Restricted stock units granted on 2026-07-05 in lieu of retainer fees

Price per RSU $0.0000 per share Reported transaction price for RSU grant

Shares held after grant 191,877 shares Total direct common stock holdings after RSU award

Transaction code A Grant, award, or other acquisition of common stock

Transaction date 2026-07-05 Date of RSU grant reported on Form 4

Key Terms

restricted stock units ("RSUs"), Non-Employee Director Compensation Program, retainer fees, settlement

4 terms

restricted stock units ("RSUs") financial

"Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Non-Employee Director Compensation Program financial

"granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees"

retainer fees financial

"granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees"

settlement financial

"with settlement to take place either (i) on a date selected by the Reporting Person"

Settlement is the process of completing a financial transaction, like buying or selling a stock, by transferring money and ownership between parties. It ensures that both the buyer gets the asset and the seller gets paid, making the deal official. Without settlement, the transaction wouldn't be finalized or legally recognized.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/07/2026 - 07:25 PM Accepted by SEC EDGAR 07/07/2026 - 07:24 PM

FAQ

What insider transaction did Omada Health (OMDA) report for Jonathan D. Root?

Omada Health reported that director Jonathan D. Root received a grant of 820 restricted stock units. These units were issued under the Non-Employee Director Compensation Program in lieu of retainer fees and represent future rights to shares of common stock with no cash purchase price.

How many Omada Health (OMDA) shares does Jonathan D. Root hold after this Form 4?

After this grant, Jonathan D. Root holds 191,877 shares of Omada Health common stock directly. This total includes the 820 restricted stock units granted, each of which corresponds to one share of common stock upon settlement under the program.

What are the terms of the 820 RSUs granted to Jonathan D. Root at Omada Health (OMDA)?

The 820 RSUs represent rights to receive one share of Omada Health common stock each. They were granted instead of cash retainer fees and will settle either on a date selected by Root under the program or as otherwise provided by the Non-Employee Director Compensation Program.

Did Jonathan D. Root pay a purchase price for the Omada Health (OMDA) RSU grant?

No purchase price was paid for this RSU grant; the reported price per share is 0.0000. The units were issued as compensation in lieu of cash retainer fees under Omada Health’s Non-Employee Director Compensation Program for non-employee directors.

How do the Omada Health (OMDA) RSUs for Jonathan D. Root settle into common stock?

Each RSU granted to Jonathan D. Root converts into one share of Omada Health common stock upon settlement. Settlement will occur on a date he selects consistent with the Non-Employee Director Compensation Program or as otherwise specified under that program’s terms.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROOT JONATHAN D

(Last)

(First)

(Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD., SUITE 120

(Street)

SOUTH SAN FRANCISCO

CALIFORNIA

94080

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/05/2026		A		820⁽¹⁾	A	$0	191,877	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

	/s/ Nathan Salha, as Attorney-in-Fact for Jonathan D. Root	07/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR